Healthcare / Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

MYGN stock hub

Myriad Genetics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

MYGNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

405.2M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

MYGN

In the news

Latest news · MYGN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E32.9

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-76.7

P25 -105.6P50 -46.5P75 -3.1

ROIC-15

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All MYGN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

223

Groups with data

Currency

USD

Showing 223 of 223 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000899923
Company name	Myriad Genetics, Inc.
Country	United States
Country code	US
Cusip	62855J104
Employees	2,700
Employees Change	100%
Employees Change Percent	3.85
Enterprise value	$492.3M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Diagnostics & Research
IPO Date	1995-10-05
Isin	US62855J1043
Last refreshed	2026-05-10
Market cap	$405.2M
Market cap category	Small-Cap
Price	$4.29
Price currency	USD
Rev Per Employee	307,037.04x
Sector	Healthcare
Sic	2835
Symbol	MYGN
Website	https://www.myriad.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-98.7%
EV Sales Forward	0.55x
EV/Sales	0.59x
FCF yield	-3.28%
Forward P/E	32.9x
P/B ratio	1.2x
P/S ratio	0.49x
PEG ratio	0.85x
PS Forward	0.45x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-7.73%
EBITDA Margin	-1.48%
Gross margin	69.96%
Gross Profit	$580M
Gross Profit Growth	-0.34%
Gross Profit Growth Q	2.53%
Gross Profit Growth3 Y	6.4%
Gross Profit Growth5 Y	8.39%
Net Income	$-399.9M
Net Income Growth Years	0%
Pretax Margin	-48.23%
Profit Margin	-48.24%
Profit Per Employee	$-148,111
ROA	-4.77
Roa5y	-5.91
ROCE	-11.79
ROE	-76.73
Roe5y	-26.44
ROIC	-15.04
Roic5y	-13.93

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-18.78%
Cagr15y	-10.51%
Cagr1y	0.47%
Cagr20y	-5.6%
Cagr3y	-39.41%
Cagr5y	-31.41%
EPS Growth Years	0
OCF Growth10 Y	-35.02%
OCF Growth5 Y	-38.86%
Revenue Growth	-0.28x
Revenue Growth Q	2.3x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	6.07x
Revenue Growth5 Y	7.93x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.99
Assets	$673.7M
Cash	$124.4M
Current Assets	$312.8M
Current Liabilities	$130.2M
Debt	$211.5M
Debt EBITDA	$51.9
Debt Equity	$0.63
Equity	$337.4M
Interest Coverage	-4.64
Liabilities	$336.3M
Long Term Assets	$360.9M
Long Term Liabilities	$206.1M
Net Cash	$-87.1M
Net Cash By Market Cap	$-21.5
Net Debt Equity	$0.26
Tangible Book Value	$144.6M
Tangible Book Value Per Share	$1.53
WACC	11.1

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.4
Inventory Turnover	8.86
Net Working Capital	$65.3M
Quick ratio	1.91
Working Capital	$182.6M
Working Capital Turnover	$5.2

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.42%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-87.51%
1Y total return	0.47%
200-day SMA	6.04
3Y total return	-77.76%
50-day SMA	4.77
50-day SMA vs 200-day SMA	50under200
5Y total return	-84.81%
All Time High	69
All Time High Change	-93.78%
All Time High Date	2000-11-06
All Time Low	1.44
All Time Low Change	198.33%
All Time Low Date	1998-08-31
ATR	0.35
Beta	1.81
Beta1y	3.06
Beta2y	1.68
Ch YTD	-30.24
High	4.38
High52	8.59
High52 Date	2025-10-16
High52ch	-50.06%
Low	4
Low52	3.75
Low52 Date	2026-05-06
Low52ch	14.4%
Ma50ch	-9.97%
Price vs 200-day SMA	-28.95%
RSI	40.64
RSI Monthly	33.47
RSI Weekly	38.05
Sharpe ratio	0.32x
Sortino ratio	0.63
Total Return	-2.42%
Tr YTD	-30.24
Tr15y	-81.09%
Tr1m	-9.49%
Tr1w	-10.62%
Tr3m	-16.21%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	6
Analyst Ratings	Hold
Earnings EPS Estimate	$-0.09
Earnings Revenue Estimate	202,473,928x
Earnings Revenue Estimate Growth	3.36x
Operating Income	$-64.1M
Operating margin	-7.73
Price target	$6.83
Price Target Change	$59.21

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	79,083,448%
Float Percent	83.73%
Net Borrowing	65,000,000
Shares Insiders	3.9%
Shares Institutions	79.96%
Shares Out	94,448,210
Shares Qo Q	0.43%
Shares Yo Y	2.42%
Short Float	10.42%
Short Ratio	3.9
Short Shares	8.72

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-45.5M
Average Volume	1,480,388.55x
Bv Per Share	3.57
CAPEX	$-15.7M
Ch10y	-87.51
Ch15y	-81.09
Ch1m	-9.49
Ch1w	-10.62
Ch1y	0.47
Ch20y	-69.86
Ch3m	-16.21
Ch3y	-77.76
Ch5y	-84.81
Ch6m	-31.9
Change	4.89%
Change From Open	3.87
Close	4.09
Days Gap	0.98
Depreciation Amortization	51,800,000
Dollar Volume	8,509,099.2
Earnings Date	2026-05-05
Earnings Time	amc
EBIT	$-64.1M
EBITDA	$-12.3M
EPS	$-4.29
F Score	4
FCF	$-13.3M
FCF EV Yield	-2.7x
FCF Per Share	$-0.14
Financing CF	47,600,000
Fiscal Year End	December
Founded	1,991
Goodwill	47,100,000
Income Tax	$100,000
Investing CF	-25,600,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Last Split Date	2009-03-26
Last Split Type	Forward
Last10k Filing Date	2026-02-24
Ma150	5.97
Ma150ch	-28.08%
Ma20	4.8
Ma20ch	-10.55%
Net CF	25,000,000
Next Earnings Date	2026-08-04
Open	4.13
Optionable	Yes
P OCF Ratio	168.8
Position In Range	77.33
Post Close	4.29
Postmarket Change Percent	0.47
Postmarket Price	$4.31
Ppne	162,500,000
Price Date	2026-05-08
Ptbv Ratio	2.8
Relative Volume	1.34x
Revenue	829,000,000x
SBC By Revenue	3.88x
Share Based Comp	32,200,000
Tax By Revenue	0.01x
Tr20y	-68.4%
Tr6m	-31.9%
Us State	Utah
Volume	1,983,473
Z Score	-0.15

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does MYGN pay a dividend?

Capital-return profile for this ticker.

Performance

MYGN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns MYGN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+80.0%

Float: +83.7% of shares outstanding

Insider ownership

+3.9%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

MYGN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

40.6

Neutral momentum band

Price vs 200-day MA

-28.9%

50/200-day relationship not available

Beta (5Y)

1.81

More volatile than the market

Sharpe ratio

0.32

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About MYGN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current MYGN stock rating?

Myriad Genetics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full MYGN analysis?

The full report lives at /stocks/MYGN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for MYGN?

The latest report frames MYGN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the MYGN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.